Cargando…

Identification of significant genes and therapeutic agents for breast cancer by integrated genomics

Breast cancer is the most commonly diagnosed malignancy in women; thus, more cancer prevention research is urgently needed. The aim of this study was to predict potential therapeutic agents for breast cancer and determine their molecular mechanisms using integrated bioinformatics. Summary data from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Xiao, Luo, Zhenzhen, Gong, Liuyun, Tan, Xinyue, Chen, Jie, Liang, Xin, Cai, Mengjiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806825/ https://www.ncbi.nlm.nih.gov/pubmed/34151730 http://dx.doi.org/10.1080/21655979.2021.1931642

Ejemplares similares

Tamoxifen induces fatty liver disease in breast cancer through the MAPK8/FoxO pathway
por: Gong, Liuyun, et al.
Publicado: (2020)

Integrating Genome-Wide Association Studies and Gene Expression Profiles With Chemical-Genes Interaction Networks to Identify Chemicals Associated With Colorectal Cancer
por: Tan, Xinyue, et al.
Publicado: (2020)

Transcriptome‐wide association study identifies multiple genes and pathways associated with pancreatic cancer
por: Gong, Liuyun, et al.
Publicado: (2018)

Chemerin regulates autophagy to participate in polycystic ovary syndrome
por: Luo, Xiaodong, et al.
Publicado: (2021)

Identification of Gene Expression Pattern Related to Breast Cancer Survival Using Integrated TCGA Datasets and Genomic Tools
por: Huang, Zhenzhen, et al.
Publicado: (2015)

Identification of significantly mutated subnetworks in the breast cancer genome
por: Ajwad, Rasif, et al.
Publicado: (2021)

Identification of triptonide as a therapeutic agent for triple negative breast cancer treatment
por: Gao, Bowen, et al.
Publicado: (2021)

Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis
por: Dai, Jian-bo, et al.
Publicado: (2020)

Identification of the cuproptosis-related hub genes and therapeutic agents for sarcopenia
por: Zhu, Yingqian, et al.
Publicado: (2023)

DisSim: an online system for exploring significant similar diseases and exhibiting potential therapeutic drugs
por: Cheng, Liang, et al.
Publicado: (2016)

The Role of Ferroptosis in Cardiovascular Disease and Its Therapeutic Significance
por: Chen, Zhenzhen, et al.
Publicado: (2021)

Integrated bioinformatics analysis for the identification of idiopathic pulmonary fibrosis–related genes and potential therapeutic drugs
por: Zhang, Zhenzhen, et al.
Publicado: (2023)

Identification of key genes, pathways and potential therapeutic agents for liver fibrosis using an integrated bioinformatics analysis
por: Zhan, Zhu, et al.
Publicado: (2019)

Profiles of alternative splicing landscape in breast cancer and their clinical significance: an integrative analysis based on large-sequencing data
por: Du, Jun-Xian, et al.
Publicado: (2021)

Dynamic Nomogram Based on the Metastatic Number and Sites and Therapy Strategies Predicting the Prognosis of Patients with Metastatic Cervical Cancer
por: Ma, Yuan, et al.
Publicado: (2022)

Genome-wide identification of significant aberrations in cancer genome
por: Yuan, Xiguo, et al.
Publicado: (2012)

Identification of key genes, pathways and potential therapeutic agents for IgA nephropathy using an integrated bioinformatics analysis
por: Chen, Xiaoxue, et al.
Publicado: (2020)

Identification of Breast Cancer Subtypes by Integrating Genomic Analysis with the Immune Microenvironment
por: Ding, Ran, et al.
Publicado: (2023)

Cocktail hepatocarcinoma therapy by a super-assembled nano-pill targeting XPO1 and ATR synergistically
por: Gong, Liuyun, et al.
Publicado: (2023)

Plasma membrane integrity in health and disease: significance and therapeutic potential
por: Dias, Catarina, et al.
Publicado: (2021)

Systematic Identification and Assessment of Therapeutic Targets for Breast Cancer Based on Genome-Wide RNA Interference Transcriptomes
por: Liu, Yang, et al.
Publicado: (2017)

BET inhibitors as novel therapeutic agents in breast cancer
por: Ocaña, Alberto, et al.
Publicado: (2017)

The SPOP-ITCH Signaling Axis Protects Against Prostate Cancer Metastasis
por: Ma, Jinlu, et al.
Publicado: (2021)

Discovery and identification of the prognostic significance and potential mechanism of FMO2 in breast cancer
por: Wu, Lichun, et al.
Publicado: (2023)

Chromosome microarray analysis combined with karyotype analysis is a powerful tool for the detection in pregnant women with high-risk indicators
por: Qian, Guanhua, et al.
Publicado: (2023)

Emerging Significance and Therapeutic Potential of Extracellular vesicles
por: Luo, Ruhua, et al.
Publicado: (2021)

NTCP Change in Rats of Hilar Cholangiocarcinoma and Therapeutic Significance
por: Zhang, Meng-yu, et al.
Publicado: (2022)

RECQL5 plays an essential role in maintaining genome stability and viability of triple‐negative breast cancer cells
por: Peng, Jin, et al.
Publicado: (2019)

Data-Driven identification of chemopreventive agents for breast cancer
por: GÜVEN, Deniz Can, et al.
Publicado: (2020)

Integrative Analysis of Sirtuins and Their Prognostic Significance in Clear Cell Renal Cell Carcinoma
por: Tan, Ying, et al.
Publicado: (2020)

Expression of Axl and its prognostic significance in human breast cancer
por: Jin, Gaoyuan, et al.
Publicado: (2017)

Application of Radiosensitizers in Cancer Radiotherapy
por: Gong, Liuyun, et al.
Publicado: (2021)

Integration of Multiple Genomic and Phenotype Data to Infer Novel miRNA-Disease Associations
por: Shi, Hongbo, et al.
Publicado: (2016)

Integrative Analysis of Minichromosome Maintenance Proteins and Their Prognostic Significance in Melanoma
por: Han, Wei, et al.
Publicado: (2021)

Andrographolide as a Therapeutic Agent Against Breast and Ovarian Cancers
por: Beesetti, Swarna Latha, et al.
Publicado: (2019)

Fucoxanthin Is a Potential Therapeutic Agent for the Treatment of Breast Cancer
por: Lau, Tsz-Ying, et al.
Publicado: (2022)

Vitamin D: an essential adjuvant therapeutic agent in breast cancer
por: Thabet, Romany H, et al.
Publicado: (2022)

Integrative multi-omics analysis unveils stemness-associated molecular subtypes in prostate cancer and pan-cancer: prognostic and therapeutic significance
por: Zheng, Kun, et al.
Publicado: (2023)

CeModule: an integrative framework for discovering regulatory patterns from genomic data in cancer
por: Xiao, Qiu, et al.
Publicado: (2019)

Integrative genomic and transcriptomic analysis for pinpointing recurrent alterations of plant homeodomain genes and their clinical significance in breast cancer
por: Yu, Huimei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ntrrils3l50e8jkkjfqf4kltos